SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-22-000012
Filing Date
2022-11-14
Accepted
2022-11-14 07:08:37
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20220930.htm   iXBRL 10-Q 1759230
2 EX-10.1 a2022-07x29bixwatchfactory.htm EX-10.1 116049
3 EX-31.1 ex311_2022-09.htm EX-31.1 11321
4 EX-31.2 ex312_2022-09.htm EX-31.2 13083
5 EX-32.1 ex321_2022-09.htm EX-32.1 9900
11 image_0.jpg GRAPHIC 95182
12 image_1.jpg GRAPHIC 31129
13 image_2.jpg GRAPHIC 50611
14 image_3.jpg GRAPHIC 45646
15 image_4.jpg GRAPHIC 135733
  Complete submission text file 0001590750-22-000012.txt   7900087

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20220930.xsd EX-101.SCH 43766
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20220930_cal.xml EX-101.CAL 59115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20220930_def.xml EX-101.DEF 271976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20220930_lab.xml EX-101.LAB 588419
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20220930_pre.xml EX-101.PRE 376352
62 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20220930_htm.xml XML 1139478
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 221380134
SIC: 8071 Services-Medical Laboratories